SAN FRANCISCO — In the past, medical device companies may have gotten away with waiting until later in the development process or even late into the regulatory process to start thinking about reimbursement. Today, thinking upfront about who will pay for the device and how it will be reimbursed is critical, according to a panel of experts at the OneMedForum meeting.